バイオバンクの市場規模、シェア、動向分析レポート：製品・サービス別、生体試料タイプ別、バイオバンクのタイプ別、用途別、地域別、セグメント別予測、2025-2030年

バイオバンク市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のバイオバンク市場規模は2030年に1,266億9,000万米ドルに達し、2025年から2030年にかけてCAGR 7.85％で成長すると予測されています。

バイオバンクは、NGSなどの新技術の導入やゲノム医療への注目の高まりとともに進化し続けています。創薬、診断、その他を含む複数の領域に対応するために複数の種類の生物試料の利用が可能であることが、バイオバンクの多様化を加速し、市場を牽引しています。生物試料の質は、疾患検査や前臨床・臨床研究に大きな影響を与えます。規制機関は、サンプルの効果的な管理のためのガイドラインを確立することで、バイオバンキング・サービスの採用に拍車をかける重要な役割を果たしています。

例えば、米国疾病予防管理センター（CDC）は、COVID-19サンプルの取り扱い中の人体への危険を最小限に抑えるためのガイドラインを発表しました。これは他のバイオリポジトリのモデルとなっています。さらに、COVID-19に関連する研究および臨床試験の数が増加しているため、近い将来、高品質の生物試料の需要が大幅に増加し、市場の成長につながると予想されます。さらに、集団ベースのコホート研究は、実際の血清有病率を推定するためにバイオレポジトリによって促進されます。Health Catalyst, Inc.は、そのTouchstoneプラットフォームを通じて、COVID-19の洞察に関連する全国データを提供しています。このような要因がこの分野の収益に貢献すると予想されます。

BioResource」は2021年10月、ヘクサムに本拠を置くヘルスケア新興企業で、珍しい形態のがんの研究を改善することに専念するRareCan社によって創設されました。BioResourceは、がん患者の手術後に採取されたサンプルを保持し、病気の治療、予防、特定に利用できる世界中の研究者がアクセスできるようにします。2021年12月、ニューカッスル大学はヒト血液サンプルとヒト組織提供の新たなコレクションを導入しました。英国バイオバンクは、循環メタボロミクスバイオマーカーの範囲を測定する研究から得られた新鮮なデータをデータベースに追加したと発表しました。血液バイオマーカー技術を専門とするフィンランドの企業ナイチンゲール・ヘルス社は、12万人の参加者を対象にこの研究を実施しました。

さらに、米国ではCOVID-19の症例数が多く、研究開発プログラムの増加が新たなバイオリポジトリの設立につながっており、これが北米の収益を牽引しています。アジア太平洋地域では、アジア諸国における医薬品と臨床研究の領域が拡大し続けているため、市場は最も速い成長を記録すると予想されています。主要企業は、世界の流通業者との提携、他企業の合併・買収、研究コミュニティとの戦略的提携などにより、世界のリーチの拡大に取り組んでいます。

バイオバンク市場レポートハイライト

• バイオバンキング機器分野は、バイオリポジトリ数の増加と機器の高コストにより、2024年に最大の売上シェアを占めました。
• バイオバンキングおよびリポジトリサービス分野は、これらのサービスの普及率の高さと、精密医療や疾患特異的研究開発のためのバイオサンプルの保存ニーズの高まりにより、2024年に最大の収益シェアを占めました。
• ヒト組織は臨床研究で最も保存されているサンプルであり、その結果、このサンプルタイプが市場で優位を占めています。
• 仮想バイオバンク分野は、生物医学研究のための希少疾患データの必要性と3D生物試料の需要の高まりにより、予測期間中に最も速いCAGRを記録すると予測されています。
• 2024年には、がん治療のための細胞治療の人気の高まりにより、治療薬アプリケーション分野が最大の収益シェアを占めました。
• 非公開の製薬/バイオテクノロジー会社が臨床試験や細胞療法の開発を支援するためにプライベートバンクを設立した結果、このセグメントの企業収益が伸びています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 バイオバンク市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• バイオバンク市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 バイオバンク市場：製品・サービス別　推定・動向分析

• セグメントダッシュボード
• 製品・サービス別市場シェア、2024年・2030年
• 製品
• 2018年～2030年までの市場規模と予測および動向分析
  • バイオバンク機器
  • バイオバンキング消耗品
  • 研究室情報管理システム
• サービス
• 2018年～2030年までの市場規模と予測および動向分析
  • バイオバンキングとリポジトリ
  • ラボ処理
  • 資格/検証
  • コールドチェーン物流
  • その他のサービス

第5章 バイオバンク市場：生体試料タイプ別　推定・動向分析

• セグメントダッシュボード
• 生体試料タイプ別市場シェア、2024年・2030年
• 2018年～2030年までの市場規模と予測および動向分析
  • ヒト組織
  • 人間の臓器
  • 幹細胞
  • その他の生体標本

第6章 バイオバンク市場：バイオバンクのタイプ別　推定・動向分析

• セグメントダッシュボード
• バイオバンクのタイプ別の市場シェア、2024年・2030年
• 2018年～2030年までの市場規模と予測および動向分析
  • 物理的/現実のバイオバンク
  • 仮想バイオバンク

第7章 バイオバンク市場：用途別　推定・動向分析

• セグメントダッシュボード
• 用途別市場シェア、2024年・2030年
• 2018年～2030年までの市場規模と予測および動向分析
  • 治療薬
  • 創薬と臨床調査
  • 臨床診断
  • その他の用途

第8章 バイオバンク市場：地域別　推定・動向分析

• 地域市場ダッシュボード
• 地域別市場シェア分析、2024年・2030年
• 市場規模、予測動向分析、2018年～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Qiagen
  • Hamilton Company
  • Tecan Trading AG
  • Danaher Corporation
  • Becton, Dickinson, and Company（BD）
  • Biocision, LLC.
  • Taylor-Wharton
  • Charles River Laboratories
  • Lonza
  • Stemcell Technologies
  • Biovault Family
  • Promocell GmbH
  • Precision Cellular Storage Ltd.（Virgin Health Bank）

List of Tables

• Table 1 List of abbreviation
• Table 2 North America biobanks market, by region, 2018 - 2030 (USD Million)
• Table 3 North America biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 4 North America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 5 North America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 6 North America biobanks market, by application, 2018 - 2030 (USD Million)
• Table 7 U.S. biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 8 U.S. biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 9 U.S. biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 10 U.S. biobanks market, by application, 2018 - 2030 (USD Million)
• Table 11 Mexico biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 12 Mexico biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 13 Mexico biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 14 Mexico biobanks market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 16 Canada biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 17 Canada biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 18 Canada biobanks market, by application, 2018 - 2030 (USD Million)
• Table 19 Europe biobanks market, by region, 2018 - 2030 (USD Million)
• Table 20 Europe biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 21 Europe biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 22 Europe biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 23 Europe biobanks market, by application, 2018 - 2030 (USD Million)
• Table 24 Germany biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 25 Germany biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 26 Germany biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 27 Germany biobanks market, by application, 2018 - 2030 (USD Million)
• Table 28 UK biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 29 UK biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 30 UK biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 31 UK biobanks market, by application, 2018 - 2030 (USD Million)
• Table 32 France biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 33 France biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 34 France biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 35 France biobanks market, by application, 2018 - 2030 (USD Million)
• Table 36 Italy biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 37 Italy biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 38 Italy biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 39 Italy biobanks market, by application, 2018 - 2030 (USD Million)
• Table 40 Spain biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 41 Spain biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 42 Spain biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 43 Spain biobanks market, by application, 2018 - 2030 (USD Million)
• Table 44 Denmark biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 45 Denmark biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 46 Denmark biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 47 Denmark biobanks market, by application, 2018 - 2030 (USD Million)
• Table 48 Sweden biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 49 Sweden biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 50 Sweden biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 51 Sweden biobanks market, by application, 2018 - 2030 (USD Million)
• Table 52 Norway biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 53 Norway biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 54 Norway biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 55 Norway biobanks market, by application, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific biobanks market, by region, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific biobanks market, by application, 2018 - 2030 (USD Million)
• Table 61 China biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 62 China biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 63 China biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 64 China biobanks market, by application, 2018 - 2030 (USD Million)
• Table 65 Japan biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 66 Japan biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 67 Japan biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 68 Japan biobanks market, by application, 2018 - 2030 (USD Million)
• Table 69 India biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 70 India biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 71 India biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 72 India biobanks market, by application, 2018 - 2030 (USD Million)
• Table 73 South Korea biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 74 South Korea biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 75 South Korea biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 76 South Korea biobanks market, by application, 2018 - 2030 (USD Million)
• Table 77 Australia biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 78 Australia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 79 Australia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 80 Australia biobanks market, by application, 2018 - 2030 (USD Million)
• Table 81 Thailand biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 82 Thailand biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 83 Thailand biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 84 Thailand biobanks market, by application, 2018 - 2030 (USD Million)
• Table 85 Latin America biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 86 Latin America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 87 Latin America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 88 Latin America biobanks market, by application, 2018 - 2030 (USD Million)
• Table 89 Brazil biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 90 Brazil biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 91 Brazil biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 92 Brazil biobanks market, by application, 2018 - 2030 (USD Million)
• Table 93 Argentina biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 94 Argentina biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 95 Argentina biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 96 Argentina biobanks market, by application, 2018 - 2030 (USD Million)
• Table 97 MEA biobanks market, by region, 2018 - 2030 (USD Million)
• Table 98 MEA biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 99 MEA biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 100 MEA biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 101 MEA biobanks market, by application, 2018 - 2030 (USD Million)
• Table 102 South Africa biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 103 South Africa biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 104 South Africa biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 105 South Africa biobanks market, by application, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia biobanks market, by application, 2018 - 2030 (USD Million)
• Table 110 UAE biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 111 UAE biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 112 UAE biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 113 UAE biobanks market, by application, 2018 - 2030 (USD Million)
• Table 114 Kuwait biobanks market, by product & services, 2018 - 2030 (USD Million)
• Table 115 Kuwait biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
• Table 116 Kuwait biobanks market, by biobanks type, 2018 - 2030 (USD Million)
• Table 117 Kuwait biobanks market, by application, 2018 - 2030 (USD Million)

List of Tables

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Biobanks market: market outlook
• Fig. 9 Biobanks competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Biobanks market driver impact
• Fig. 15 Biobanks market restraint impact
• Fig. 16 Biobanks market strategic initiatives analysis
• Fig. 17 Biobanks market: Product & services movement analysis
• Fig. 18 Biobanks market: Product & services outlook and key takeaways
• Fig. 19 Product market estimates and forecast, 2018 - 2030
• Fig. 20 Biobanking equipment market estimates and forecast, 2018 - 2030
• Fig. 21 Temperature control systems estimates and forecast, 2018 - 2030
• Fig. 22 Freezers & refrigerators market estimates and forecast, 2018 - 2030
• Fig. 23 Cryogenic storage systems market estimates and forecast, 2018 - 2030
• Fig. 24 Thawing equipment market estimates and forecast, 2018 - 2030
• Fig. 25 Incubators & centrifuges market estimates and forecast, 2018 - 2030
• Fig. 26 Alarms & monitoring systems market estimates and forecast, 2018 - 2030
• Fig. 27 Accessories & other equipment market estimates and forecast, 2018 - 2030
• Fig. 28 Biobanking consumables market estimates and forecast, 2018 - 2030
• Fig. 29 Laboratory information management systems market estimates and forecast, 2018 - 2030
• Fig. 30 Services market estimates and forecasts, 2018 - 2030
• Fig. 31 Biobanking & repository market estimates and forecasts, 2018 - 2030
• Fig. 32 Lab processing market estimates and forecasts,2018 - 2030
• Fig. 33 Qualification/ Validation market estimates and forecasts,2018 - 2030
• Fig. 34 Cold chain logistics market estimates and forecasts, 2018 - 2030
• Fig. 35 Other services market estimates and forecasts,2018 - 2030
• Fig. 36 Biobanks market: Biospecimen type movement analysis
• Fig. 37 Biobanks market: Biospecimen type outlook and key takeaways
• Fig. 38 Human tissues market estimates and forecasts, 2018 - 2030
• Fig. 39 Human organs market estimates and forecasts,2018 - 2030
• Fig. 40 Stem cells market estimates and forecasts, 2018 - 2030
• Fig. 41 Adult stem cells market estimates and forecasts,2018 - 2030
• Fig. 42 Embryonic stem cells market estimates and forecasts, 2018 - 2030
• Fig. 43 IPS cells market estimates and forecasts, 2018 - 2030
• Fig. 44 Other stem cells market estimates and forecasts, 2018 - 2030
• Fig. 45 Other biospecimens market estimates and forecasts, 2018 - 2030
• Fig. 46 Biobanks market: Biobanks type movement analysis
• Fig. 47 Biobanks market: Biobanks type outlook and key takeaways
• Fig. 48 Physical/Real biobanks market estimates and forecasts, 2018 - 2030
• Fig. 49 Tissue biobanks market estimates and forecasts,2018 - 2030
• Fig. 50 Population based biobanks market estimates and forecasts, 2018 - 2030
• Fig. 51 Genetic (DNA/RNA) market estimates and forecasts,2018 - 2030
• Fig. 52 Disease based biobanks market estimates and forecasts, 2018 - 2030
• Fig. 53 Virtual biobanks market estimates and forecasts, 2018 - 2030
• Fig. 54 Biobanks market: Application movement analysis
• Fig. 55 Biobanks market: Application outlook and key takeaways
• Fig. 56 Therapeutics market estimates and forecasts, 2018 - 2030
• Fig. 57 Drug discovery & clinical research market estimates and forecasts,2018 - 2030
• Fig. 58 Clinical diagnostics market estimates and forecasts, 2018 - 2030
• Fig. 59 Other applications market estimates and forecasts,2018 - 2030
• Fig. 60 Global Biobanks market: Regional movement analysis
• Fig. 61 Global Biobanks market: Regional outlook and key takeaways
• Fig. 62 North America, by country
• Fig. 63 North America
• Fig. 64 North America market estimates and forecasts, 2018 - 2030
• Fig. 65 U.S. country dynamics
• Fig. 66 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 67 Canada country dynamics
• Fig. 68 Canada market estimates and forecasts, 2018 - 2030
• Fig. 69 Mexico country dynamics
• Fig. 70 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 71 Europe market estimates and forecasts, 2018 - 2030
• Fig. 72 UK country dynamics
• Fig. 73 UK market estimates and forecasts, 2018 - 2030
• Fig. 74 Germany country dynamics
• Fig. 75 Germany market estimates and forecasts, 2018 - 2030
• Fig. 76 France country dynamics
• Fig. 77 France market estimates and forecasts, 2018 - 2030
• Fig. 78 Italy country dynamics
• Fig. 79 Italy market estimates and forecasts, 2018 - 2030
• Fig. 80 Spain country dynamics
• Fig. 81 Spain market estimates and forecasts, 2018 - 2030
• Fig. 82 Denmark country dynamics
• Fig. 83 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 84 Sweden country dynamics
• Fig. 85 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 86 Norway country dynamics
• Fig. 87 Norway market estimates and forecasts, 2018 - 2030
• Fig. 88 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 89 China country dynamics
• Fig. 90 China market estimates and forecasts, 2018 - 2030
• Fig. 91 Japan country dynamics
• Fig. 92 Japan market estimates and forecasts, 2018 - 2030
• Fig. 93 India country dynamics
• Fig. 94 India market estimates and forecasts, 2018 - 2030
• Fig. 95 Thailand country dynamics
• Fig. 96 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 97 South Korea country dynamics
• Fig. 98 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 99 Australia country dynamics
• Fig. 100 Australia market estimates and forecasts, 2018 - 2030
• Fig. 101 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 102 Brazil country dynamics
• Fig. 103 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 104 Argentina country dynamics
• Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 106 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 107 South Africa country dynamics
• Fig. 108 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 109 Saudi Arabia country dynamics
• Fig. 110 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 111 UAE country dynamics
• Fig. 112 UAE market estimates and forecasts, 2018 - 2030
• Fig. 113 Kuwait country dynamics
• Fig. 114 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 115 Market position of key market players- Biobanks market

Biobanks Market Growth & Trends:

The global biobanks market size is expected to reach USD 126.69 billion in 2030 and is expected to grow at a CAGR of 7.85% from 2025 to 2030, according to a new report by Grand View Research, Inc. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.

For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

The 'BioResource' was created in October 2021 by RareCan, a Hexham-based healthcare start-up dedicated to improving studies into the uncommon forms of cancer. BioResource will retain samples taken after surgery from cancer patients and make them accessible to researchers across the globe who can use them to cure, prevent, and identify the disease. In December 2021, Newcastle University introduced a new collection of human blood samples and donated human tissue, which could transform efforts to cure rare cancers. The U.K. Biobank has announced that fresh data from a study measuring the range of circulatory metabolomics biomarkers has been added to its database. Nightingale Health, a Finnish business specializing in blood biomarker technologies, conducted the study with 120000 participants.

North America dominated the market with its wide network of centers for biosample storage in the U.S. Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving revenue in North America. In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across Asian countries. The key players are engaged in expanding their global reach by partnering with global distributors, mergers, and acquisitions of other players, and entering a strategic alliance with research communities.

Biobanks Market Report Highlights:

• The biobanking equipment segment accounted for the maximum revenue share in 2024 owing to the high cost of instruments coupled with an increase in the number of biorepositories
• The biobanking and repository services segment accounted for the largest revenue share in 2024 due to the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research
• Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
• The virtual biobanks segment is anticipated to witness the fastest CAGR during the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
• The therapeutics application segment accounted for the largest revenue share in 2024 owing to the growing popularity of cell therapies for cancer treatment
• Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product & Services
  • 1.2.2. Biospecimen Type
  • 1.2.3. Biobanks Type
  • 1.2.4. Application
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Biobanks Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
    • 3.2.1.2. Increased focus on precision medicine and genetic testing
    • 3.2.1.3. Changes in biobanking operations
    • 3.2.1.4. Increase in the number of clinical trials globally
    • 3.2.1.5. Growing industry and research collaborations
    • 3.2.1.6. Technology advancement and automation
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Disruptions in supply chain management due to COVID-19
    • 3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
    • 3.2.2.3. Sustainability challenges for biobanks
    • 3.2.2.4. Other challenges in biobanking specimens for research
• 3.3. Biobanks Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Biobanks Market: Product & Services Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Product & Services Market Share, 2024 & 2030
• 4.3. Product
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Biobank Equipment
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Temperature Control Systems
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2.2. Freezers & Refrigerators
        • 4.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2.3. Cryogenic Storage Systems
      • 4.4.1.2.4. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2.5. Thawing Equipment
      • 4.4.1.2.6. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Incubators & Centrifuges
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Alarms & Monitoring Systems
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.5. Accessories & Other Equipment
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Biobanking Consumables
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Laboratory Information Management Systems
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Services
• 4.6. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.6.1. Biobanking & repository
    • 4.6.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Lab processing
    • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Qualification/ Validation
    • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Cold Chain Logistics
    • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.5. Other Services
    • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Biobanks Market: Biospecimen Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Biospecimen Type Market Share, 2024 & 2030
• 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.3.1. Human Tissues
    • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 5.3.2. Human Organs
    • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Stem Cells
    • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3.2. Adult Stem Cells
      • 5.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3.3. Embryonic Stem Cells
      • 5.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3.4. IPS Cells
      • 5.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3.5. Other Stem Cells
      • 5.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Other biospecimens
    • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Biobanks Market: Biobanks Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Biobanks Type Market Share, 2024 & 2030
• 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.3.1. Physical/Real biobanks
    • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.3.1.2. Tissue Biobanks
      • 6.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.3. Population based biobanks
      • 6.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.4. Genetic (DNA/RNA)
      • 6.3.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.1.5. Disease based biobanks
      • 6.3.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Virtual biobanks
    • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Biobanks Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Application Market Share, 2024 & 2030
• 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.3.1. Therapeutics
    • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Drug discovery & clinical research
    • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Clinical Diagnostics
    • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.4. Other Applications
    • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Biobanks Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2024 & 2030
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Canada
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Mexico
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. UK
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Germany
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. France
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Italy
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Spain
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Norway
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Regulatory framework/ reimbursement structure
    • 8.5.7.3. Competitive scenario
    • 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Regulatory framework/ reimbursement structure
    • 8.5.8.3. Competitive scenario
    • 8.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Australia
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Thailand
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Argentina
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. South Africa
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. UAE
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Regulatory framework/ reimbursement structure
    • 8.8.3.3. Competitive scenario
    • 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Regulatory framework/ reimbursement structure
    • 8.8.4.3. Competitive scenario
    • 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Merck KGaA
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Qiagen
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Hamilton Company
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Tecan Trading AG
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Danaher Corporation
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Becton, Dickinson, and Company (BD)
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Biocision, LLC.
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Taylor-Wharton
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Charles River Laboratories
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Lonza
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. Stemcell Technologies
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. Biovault Family
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Product benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. Promocell GmbH
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Product benchmarking
    • 9.4.14.4. Strategic initiatives
  • 9.4.15. Precision Cellular Storage Ltd. (Virgin Health Bank)
    • 9.4.15.1. Company overview
    • 9.4.15.2. Financial performance
    • 9.4.15.3. Product benchmarking
    • 9.4.15.4. Strategic initiatives